MedPath

Follow-up of Critical COVID-19 Patients

Conditions
AKI
Coagulation Disorder
Circulatory Failure
Inflammatory Response
COVID19
ARDS
Registration Number
NCT04474249
Lead Sponsor
Uppsala University
Brief Summary

The study will follow COVID-19 patients who required intensive care after 3-6 months and one year after discharge from the ICU with functional level as well as organ function to assess recovery after COVID-19. Blood and urine will be collected for biobanking.

Detailed Description

The study will follow COVID-19 patients who required intensive care at Uppsala University Hospital and were included in the Uppsala COVID-19 biobank. The patients will be contacted after three to six months for a first follow-up with assessment of functional level in activities of daily life, psychiatric symptoms, neurological symptoms and working capacity as well as specific organ functions. The organ functions will include circulation, respiration, coagulation, immune function and kidney function. In addition, blood and urine will be collected for biobanking.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • PCR-verified Covid-19
  • Treated in ICU
Exclusion Criteria
  • Pregnant of breastfeeding

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MortalityWithin 1 year after admission to ICU.

Death

AnxietyThree to six months from discharge from ICU

Screening for anxiety using the Generalised Anxiety Disorder 7-item scale.

Renal recoveryAt follow-up one year after ICU discharge.

Return of renal function measured as CKD stage.

FrailtyThree to six months from discharge from ICU

Screening for frailty using the Clinical Frailty Scale-9.

Quality of life scoreThree to six months from discharge from ICU

Quality of Life assessed using the 36-item short form survey by RAND.

Activities of Daily LifeThree to six months from discharge from ICU

Screening of functional level for Activities of Daily Life using the 5-level EQ-5D.

Neurological recoveryThree to six months from discharge from ICU

Neurological function as assessed by a clinician

Respiratory recoveryThree to six months from discharge from ICU

Respiratory function as assessed by a clinician

Working capacityThree to six months from discharge from ICU

6 min walk test

Cognitive recoveryThree to six months from discharge from ICU

Cognitive screening using the Montreal Cognitive Assessment.

DepressionThree to six months from discharge from ICU

Screening for depression using the Patient Health Questionnaire 9.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Uppsala University Hospital

πŸ‡ΈπŸ‡ͺ

Uppsala, Sweden

Β© Copyright 2025. All Rights Reserved by MedPath